To assess the protein expressions of CMTM6 and CMTM4 in canine cancers, we firstly examined the cross-reactivities of commercially available antibodies against human CMTM6 and CMTM4 using canine CMTM6- or CMTM4-expressing cells. The gene discussed is CMTM4; the disease is cancer.